Carroll Financial Associates’s Allergan Inc AGN Stock Holding History

Carroll Financial Associates’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-55	Closed	-$12K	–	907
2014 Q4	$12K	Sell	55 -148	-73%	-$29.4K	0.01%	470
2014 Q3	$39K	Sell	203 -80	-28%	-$13.3K	0.01%	350
2014 Q2	$48K	Buy	283 +130	+85%	+$20.2K	0.01%	336
2014 Q1	$19K	Buy	153 +98	+178%	+$11.9K	0.01%	435
2013 Q4	$6K	Buy	+55	New	+$5.25K	﹤0.01%	593

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Carroll Financial Associates's AGN Position: Q1 2015 in Review

Carroll Financial Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 55 shares — an estimated $12K sold.

Carroll Financial Associates first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $48K in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Carroll Financial Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Carroll Financial Associates sold 55 Allergan Inc shares in Q1 2015, an estimated $12K.
Carroll Financial Associates first reported a position in Allergan Inc in Q4 2013 and held it in 5 quarters.
Carroll Financial Associates's Allergan Inc position peaked at $48K in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Carroll Financial Associates's 13F filing for Q1 2015, filed 23 Apr 2015.